Utilization of fluorescence in situ hybridization in the diagnosis of 230 mesenchymal neoplasms: an institutional experience.

Autor: Tanas MR (AUTHOR), Rubin BP (AUTHOR), Tubbs RR (AUTHOR), Billings SD (AUTHOR), Downs-Kelly E (AUTHOR), Goldblum JR (AUTHOR)

Publikováno v: Archives of Pathology & Laboratory Medicine. Dec2010, Vol. 134 Issue 12, p1797-1803. 7p.

Superoxide Dismutase Mimetic Avasopasem Manganese Enhances Radiation Therapy Effectiveness in Soft Tissue Sarcomas and Accelerates Wound Healing.

Autor: Zaher A; Department of Radiation Oncology, The University of Iowa, Iowa City, IA 52242, USA., Mapuskar KA; Department of Radiation Oncology, The University of Iowa, Iowa City, IA 52242, USA., Petronek MS; Department of Radiation Oncology, The University of Iowa, Iowa City, IA 52242, USA., Tanas MR; Department of Pathology, The University of Iowa, Iowa City, IA 52242, USA., Isaacson AL; Department of Pathology, The University of Iowa, Iowa City, IA 52242, USA.; Department of Pathology, The Cleveland Clinic, Cleveland, OH 44195, USA., Dodd RD; Department of Internal Medicine, Division of Hematology and Oncology, The University of Iowa, Iowa City, IA 52242, USA., Milhem M; Department of Internal Medicine, Division of Hematology and Oncology, The University of Iowa, Iowa City, IA 52242, USA., Furqan M; Department of Internal Medicine, Division of Hematology and Oncology, The University of Iowa, Iowa City, IA 52242, USA., Spitz DR; Department of Radiation Oncology, The University of Iowa, Iowa City, IA 52242, USA., Miller BJ; Department of Orthopedics and Rehabilitation, The University of Iowa, Iowa City, IA 52242, USA., Beardsley RA; Galera Therapeutics Inc., 2 West Liberty Blvd., Suite 110, Malvern, PA 19355, USA., Allen BG; Department of Radiation Oncology, The University of Iowa, Iowa City, IA 52242, USA.

Publikováno v: Antioxidants (Basel, Switzerland) [Antioxidants (Basel)] 2024 May 10; Vol. 13 (5). Date of Electronic Publication: 2024 May 10.

CDK4/6-MEK Inhibition in MPNSTs Causes Plasma Cell Infiltration, Sensitization to PD-L1 Blockade, and Tumor Regression.

Autor: Kohlmeyer JL; Molecular Medicine Graduate Program, Carver College of Medicine, University of Iowa, Iowa City, Iowa.; Department of Neuroscience and Pharmacology, Carver College of Medicine, University of Iowa, Iowa City, Iowa., Lingo JJ; Cancer Biology Graduate Program, University of Iowa, Iowa City, Iowa.; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa., Kaemmer CA; Department of Neuroscience and Pharmacology, Carver College of Medicine, University of Iowa, Iowa City, Iowa., Scherer A; Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, Iowa., Warrier A; Cancer Biology Graduate Program, University of Iowa, Iowa City, Iowa.; Medical Scientist Training Program, Carver College of Medicine, University of Iowa, Iowa City, Iowa., Voigt E; Cancer Biology Graduate Program, University of Iowa, Iowa City, Iowa.; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa.; Medical Scientist Training Program, Carver College of Medicine, University of Iowa, Iowa City, Iowa., Raygoza Garay JA; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa., McGivney GR; Cancer Biology Graduate Program, University of Iowa, Iowa City, Iowa., Brockman QR; Molecular Medicine Graduate Program, Carver College of Medicine, University of Iowa, Iowa City, Iowa., Tang A; Department of Microbiology and Molecular Cell Biology, Leroy T. Canoles Jr. Cancer Center, Eastern Virginia Medical School, Norfolk, Virginia., Calizo A; Department of Oncology, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland., Pollard K; Department of Oncology, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland., Zhang X; Division of Medical Oncology, Washington University, St. Louis, Missouri., Hirbe AC; Division of Medical Oncology, Washington University, St. Louis, Missouri., Pratilas CA; Department of Oncology, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland., Leidinger M; Department of Pathology, Carver College of Medicine, University of Iowa, Iowa City, Iowa., Breheny P; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa.; Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, Iowa., Chimenti MS; Iowa Institute of Human Genetics, Carver College of Medicine, University of Iowa, Iowa City, Iowa., Sieren JC; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa.; Department of Radiation, Carver College of Medicine, University of Iowa, Iowa City, Iowa., Monga V; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa.; Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, Iowa., Tanas MR; Molecular Medicine Graduate Program, Carver College of Medicine, University of Iowa, Iowa City, Iowa.; Cancer Biology Graduate Program, University of Iowa, Iowa City, Iowa.; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa.; Department of Pathology, Carver College of Medicine, University of Iowa, Iowa City, Iowa., Meyerholz DK; Department of Pathology, Carver College of Medicine, University of Iowa, Iowa City, Iowa., Darbro BW; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa.; Medical Scientist Training Program, Carver College of Medicine, University of Iowa, Iowa City, Iowa.; Department of Pediatrics, Carver College of Medicine, University of Iowa, Iowa City, Iowa., Dodd RD; Molecular Medicine Graduate Program, Carver College of Medicine, University of Iowa, Iowa City, Iowa.; Cancer Biology Graduate Program, University of Iowa, Iowa City, Iowa.; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa.; Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, Iowa.; Medical Scientist Training Program, Carver College of Medicine, University of Iowa, Iowa City, Iowa., Quelle DE; Molecular Medicine Graduate Program, Carver College of Medicine, University of Iowa, Iowa City, Iowa.; Department of Neuroscience and Pharmacology, Carver College of Medicine, University of Iowa, Iowa City, Iowa.; Cancer Biology Graduate Program, University of Iowa, Iowa City, Iowa.; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa.; Medical Scientist Training Program, Carver College of Medicine, University of Iowa, Iowa City, Iowa.; Department of Pathology, Carver College of Medicine, University of Iowa, Iowa City, Iowa.

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Sep 01; Vol. 29 (17), pp. 3484-3497.

PRC2 loss drives MPNST metastasis and matrix remodeling.

Autor: Brockman QR; Department of Internal Medicine.; Molecular Medicine Training Program., Scherer A; Department of Internal Medicine., McGivney GR; Department of Internal Medicine.; Cancer Biology Training Program.; Department of Molecular Physiology and Biophysics., Gutierrez WR; Department of Internal Medicine.; Cancer Biology Training Program.; Medical Scientist Training Program., Voigt AP; Molecular Medicine Training Program.; Medical Scientist Training Program.; Department of Ophthalmology and Visual Science., Isaacson AL; Department of Pathology., Laverty EA; Department of Internal Medicine., Roughton G; Department of Internal Medicine., Knepper-Adrian V; Department of Internal Medicine., Darbro B; Department of Pediatrics, and., Tanas MR; Department of Pathology., Stipp CS; Department of Molecular Physiology and Biophysics.; Department of Biology, University of Iowa, Iowa City, Iowa, USA., Dodd RD; Department of Internal Medicine.

Publikováno v: JCI insight [JCI Insight] 2022 Oct 24; Vol. 7 (20). Date of Electronic Publication: 2022 Oct 24.

TAZ-CAMTA1 and YAP-TFE3 alter the TAZ/YAP transcriptome by recruiting the ATAC histone acetyltransferase complex.

Autor: Merritt N; Department of Pathology, University of Iowa, Iowa City, United States., Garcia K; Department of Pathology, University of Iowa, Iowa City, United States.; Cancer Biology Graduate Program, University of Iowa, Iowa City, United States., Rajendran D; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, United States., Lin ZY; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, United States., Zhang X; Peter MacCallum Cancer Centre, Melbourne, Australia., Mitchell KA; Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia., Borcherding N; Department of Pathology and Immunology, Washington University, St. Louis, United States., Fullenkamp C; Department of Pathology, University of Iowa, Iowa City, United States., Chimenti MS; Iowa Institute of Human Genetics, Carver College of Medicine, University of Iowa, Iowa City, United States., Gingras AC; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, United States., Harvey KF; Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia.; Department of Anatomy and Developmental Biology and Biomedicine Discovery Institute, Monash University, Clayton, Australia., Tanas MR; Department of Pathology, University of Iowa, Iowa City, United States.; Cancer Biology Graduate Program, University of Iowa, Iowa City, United States.; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, United States.; Pathology and Laboratory Medicine, Veterans Affairs Medical Center, Iowa City, United States.

Publikováno v: ELife [Elife] 2021 Apr 29; Vol. 10. Date of Electronic Publication: 2021 Apr 29.